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    SPS Chapter Research Award Final Report 
 
Project Title Magnetic Microbubbles for Targeted Drug Release 
Name of School  Kettering University (B) 
SPS Chapter Number 3541 
Total Amount Awarded $1997.00 
Total Amount Expended $1997.00 
Project Leader Nicolaas Winter 
 
Abstract 
 
We	propose	to	synthesize	and	characterize	magnetic	microbubbles	for	examining	the	use	of	magnetic	
microbubbles	for	targeted	drug	delivery.	Using	magnetic	microbubbles	as	carriers,	we	will	test	how	well	
drugs	can	be	dispersed	by	means	of	ultrasound	and	hyperthermia. 	
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Statement of Activity 
 
Overview of Award Activity 
In this project we proposed to answer the research question: Can magnetic microbubbles (MMB) be 
used to enhance drug delivery? To do this, we have successfully synthesized magnetic nanoparticles (MNP), 
coated them with surfactant, characterized them with respect to material and size distribution, integrated the 
MNP into MMB, and characterized the MMB.  
We found that MNP synthesis was more challenging than the literature suggested. We used a standard 
co-precipitation method, but were getting inconsistent results and often failures. After a few months of refining 
our technique we determined that performing our synthesis under a non-oxidizing environment was a key factor 
in successfully synthesizing Fe3O4 MNP, which was the first key goal for the project. 
Having made the particles, we then needed to coat them with a surfactant to prevent their agglomeration 
and enable them to be made into a biocompatible solution that can be integrated into microbubbles. We chose 
dextran first because of its excellent biocompatibility, wide availability, and water-solubility. Coating with 
dextran also proved to be a challenge at first and particles would fall out of solution. Eventually we determined 
that using a higher powered probe sonicator enabled much better coating compared with the original bath 
sonicator. However, we were still unable to form MMB with dextran-coated MNP. 
We then investigated the use of oleic acid to coat the particles. Our hypothesis was that oleic acid would 
be better for MMB integration than dextran because it was hydrophobic. We found that coating the MNP with 
oleic acid was simpler than the dextran coating and we carried it out successfully. We are still investigating the 
comparative properties of MMB with dextran-coated MNP versus MMB with oleic acid-coated MNP.  
Given the multiple difficulties associated with the synthesis of the MNP and thus MMB, we have not yet 
functionalized the MNP so that a model drug can be attached. The original proposal proposed functionalizing 
dextran-coated particles, but the chemical functionalization of oleic acid is different. We are currently 
investigating how this might be performed. 
Nicolaas Winter proposed the original project. Prior to his graduation in the Spring 2014, Nathaniel 
Mosher and Emily Perkins-Harbin began working as the primary student researchers with additional 
participation by Brandon Aho (Physics), Natalie Gerdung (Chem. Eng.), and Denis Volobuev (Biology). The 
three primary student researchers were members of SPS National and four of the students were participants in 
our local Physics Club.  Several more students will be continuing work on magnetic nanoparticles and 
microbubbles in the coming year. A side project to build an enclosure unit for the ultrasonic probe sonicator 
involved an additional three students, one of whom was a member of SPS National and our local Physics Club. 
 
Description of Research - Methods, Design, and Procedures  
Nanoparticles. We have, after many trials and refinements, successfully synthesized dextran-coated iron 
oxide (Fe3O4) magnetic nanoparticles via a chemical co-precipitation method.1,2 This method, briefly, involves 
the addition of a strong base in excess to a solution containing a 1:2 molar ratio of Fe2+:Fe3+ ions under a non-
oxidizing atmosphere. The overall chemical reaction is described by:  
Fe2++2Fe3++8OH− → Fe3O4 + 4H2O 
The addition of the base causes bare Fe3O4 nanoparticles to precipitate out of solution, at which point they are 
washed and decanted. We then add the bare nanoparticles to a basic solution with the surfactant (dextran) and 
expose it to ultrasonic radiation (via an ultrasonic probe sonicator) until the dextran is fully adsorbed onto the 
surface of the nanoparticles. Dextran allows the nanoparticles to remain stable in aqueous solution because it 
provides steric repulsion between each nanoparticle, thereby preventing agglomeration and precipitation. It also 
enhances the nanoparticles’ biocompatibility, which is crucial for biological applications. We characterize the 
resulting MNP using x-ray diffraction and transmission electron microscopy (TEM) to determine phase and size 
distribution. We also prepare samples for magnetic characterization via SQUID magnetometry. 
When a MNP fluid is placed in an alternating magnetic field, the fluid will heat up as a result of energy 
dissipated from physical rotation of the particles (Brownian relaxation) and changes in the directions of the 
3 
 
particles’ internal magnetic domains (Néel relaxation), a phenomenon called magnetic fluid hyperthermia 
(MFH). To characterize the hyperthermic response of the MNP, we use an Ambrell induction system, which 
runs an alternating current through a coil to create an alternating magnetic field, thereby heating the MNP 
sample placed within the coil. The system can be adjusted to output different frequencies and magnetic field 
strengths. An optical thermometer placed in the MNP sample is used to measure the heat generated from MFH. 
The sample is insulated to minimize heat transfer to the environment, which affects the apparent heating rate. 
Any heat transfer not eliminated is accounted for in the heating rate calculation. We also investigated the 
physical mechanisms responsible for MFH by building an apparatus to enable the ferrofluid to be frozen into a 
“ferrosolid” by submerging the ferrofluid in liquid nitrogen until it froze completely. We then apply an 
alternating magnetic field to the frozen sample and compare the heating rates to those of liquid samples. 
Microbubbles. We created control (non-magnetic) microbubbles by mixing magnetic nanoparticles and 
L-α-phosphatidylcholine into a phosphate-buffered saline solution. The microbubbles formed via exposure to 
the probe sonicator for 30 s, following by manual shaking for 30 s. For the creation of magnetic microbubbles,3 
we repeat the process with the addition of the magnetic nanoparticles and another sonication step. 
We characterize the MMB primarily by viewing under a microscope. By placing the MMB in a 
hemocytometer with known scale markings, we are able to determine the size distribution. To test whether the 
MMB are actually magnetic, a 30 mT bar magnet is placed by the microscope slide containing the MMB, and 
they are viewed to see if they respond to the field.  
 
Discussion of Results 
Nanoparticles. Through x-ray diffraction, we found that the MNP were composed of Fe3O4 and Fe2O3, 
as expected. Figure 1 shows TEM imaging of a typical MNP sample, revealing that the particle size ranges from 
5‒20 nm, which is well within the range of a superparamagnetic single domain material. Magnetic 
characterization experiments are planned at an off-campus location during early 2015. 
We measured the hyperthermic ability of the MNP by exposing them to alternating magnetic fields of 
various frequencies. The heating rates of the MNPs were then calculated for each frequency to determine their 
efficacy, as described in the midyear report. The effectiveness of the heating suggests that thermally-induced 
drug release from the MNP is at least plausible. We also investigated heating mechanisms of the MNP by 
comparing the heating rate between liquid (Brownian and Néel relaxation) and frozen states (only Néel 
relaxation). Figure 2 shows the temperature of the sample as a function of time for a frozen sample. We find 
that frozen MNP typically heat at a reduced rate as compared to the liquid MNP, which makes sense because 
the Brownian motion is reduced or even completely suppressed by the immobilization of the MNP due to the 
freezing. A liquid sample heated under the same conditions as those seen in Fig. 2 would therefore have a 
steeper slope. Analysis of data and calculation of specific absorption rates (SAR in J/g) for multiple frequencies 
between 150 kHz and 350 kHz is ongoing and will be reported at the 2015 APS March Meeting.  
To determine the bioeffects of the MNP, a proof-of-concept experiment was run in cooperation with Dr. 
Hakan Demerci of the University of Michigan Kellogg Eye Center for retinoblastoma cells cultured in vitro to 
determine cytotoxicity levels and the ability of MFH to induce cell death. We found that a majority of the cells 
were killed after exposure to MFH up to 50Ԩ. Future work is planned to test the MNP in an animal model to 
get results more representative of what we could expect in the human body. 
Microbubbles. The microbubbles created with the MNP were visibly darker than the plain microbubbles, 
both macro- and microscopically. The color difference was taken as an indication that the MNP were 
incorporated with the bubbles. When placed in a field, as in Fig. 3, the MMB can be seen forming chains 
parallel to the field, suggesting that the bubbles are magnetic. These bubbles averaged 5 μm across. 
Microbubbles that did not contain MNP did not respond to the field.  
We found that we had better incorporation of the MNP into the microbubbles with oleic-acid-coated 
MNP than with dextran-coated MNP. We believe that this could be because the phosphatidylcholine forms a 
lipid monolayer with the hydrophobic tails directed in towards the air at the center of the bubble. Consequently 
the hydrophobic oleic-acid-coated nanoparticles are likely traversing the monolayer to congregate near the lipid 
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tails to minimize contact with the water. It is also possible that the bubbles are formed of lipid bilayers, and that 
the oleic acid nanoparticles will congregate between the layers for the same reason. 
 
Dissemination of Results 
 Each spring the Kettering University sponsors a “Homecoming” event for alumni to come back to campus. 
As part of this event, the university organizes a poster session for students, faculty, and staff to present their 
activities. We presented two posters related to the current project on 17 May 2014: 
o E. Perkins-Harbin, N. Mosher, R. Cunningham, L. Wang, P. Vaishnava, R. E. Kumon, “Magnetic 
Microbubbles for Biomedical Applications” 
o N. Mosher, N. Winter, E. Perkins-Harbin, N. Gerdung, R. Cunningham, C. Rablau, L. Wang, 
R. E. Kumon, P. Vaishnava, “Synthesis and Characterization of Biocompatible Magnetic Nanoparticles” 
 We also presented these posters at the Wayne State University 8th Annual Undergraduate Research 
Conference on 7 November 2014 and Discover Kettering, a recruiting day for high school students, on 8 
November 2014. The posters have been on display in the hallway outside of our lab since May 2014. 
 We were involved in the production of a video entitled “Magnetic Nanoparticles and Microbubbles” as part 
of Kettering University’s “Making a Better World” series. The video features Prof. Ronald Kumon, Prof. 
Prem Vaishnava, Nathaniel Mosher, and Emily Perkins-Harbin and was distributed via the Kettering 
University YouTube channel (https://www.youtube.com/watch?v=IJ2qi15jOaQ).  It had 402 views as of 31 
December 2014.  
 Emily Perkins-Harbin also made a presentation to her Medical Physics class on 16 December 2014, entitled 
“Enhancing Cancer Treatment with Magnetic Fluid Hyperthermia,” which was open to the public. 
 We co-authored an abstract that has been accepted for an oral presentation to the 2015 APS March Meeting: 
N. Mosher, E. Perkins-Harbin, B. Aho, L. Wang, R. Kumon, P. Vaishnava; R. Tackett, “Determination of 
the magnetocrystalline anisotropy constant from the frequency dependence of the specific absorption rate in 
a frozen ferrofluid” 
 Two senior theses are currently in preparation, with anticipated completion by April 2015: 
o Emily Perkins-Harbin, “Synthesis and Characterization of Magnetic Microbubbles” 
o Nathaniel Mosher, “Drug Delivery using Magnetically-Induced Hyperthermia and Ultrasound” 
Examples of disseminated results are included in Appendix A. 
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Impact Assessment:  
 
How the Project Influenced your Chapter 
This experience was very much worthwhile and exposed many members of our SPS chapter to many 
valuable experiences and created many opportunities. One of the biggest lessons we learned was that learning to 
work with an interdisciplinary group is invaluable. Our project extends beyond physics to chemistry and even 
biology. As such, we have had the pleasure to work with people and subject matter that we are not normally 
exposed to in physics education and came out better for it.  
This work involved work from many members from our SPS chapter and that meant working closely 
with each other for a good length of time. We came to know each other a lot better as a result. Additionally, 
because of our close work with faculty from the entire university, the SPS chapter’s ties with faculty also 
became much stronger. 
Additionally, simply being exposed to research in a university setting has given us a real taste of what 
academic research is like. Also, we are now familiar with the processes vital to academic research such as 
publishing papers, data management, presenting scientific results, etc. As a result, several members are actively 
pursuing graduate school where before they may not have. 
Our advice to other SPS chapters: don’t be afraid to work with subject matters other than physics; work 
as an interdisciplinary team and everybody will be better for it. 
 
Key Metrics and Reflection 
 
How many students from your SPS chapter were involved 
in the research, and in what capacity? 
Six students were involved in the main research 
project, four of which were active members of the 
local club. These students wrote the proposal, 
synthesized nanoparticles and microbubbles, and 
characterized the nanoparticles and microbubbles, 
and performed experiments on nanoparticle 
heating. An additional three students were 
involved in a side project. 
Was the amount of money you received from SPS 
sufficient to carry out the activities outlined in your 
proposal?  
Could you have used additional funding? If yes, how 
much would you have liked? How would the additional 
funding have augmented your activity?  
The amount of funding was sufficient for some of 
the basic supplies and equipment, but additional 
funding was needed to cover the costs of some of 
the more expensive equipment and basic 
laboratory supplies, as noted in the Expenditures 
section. 
Do you anticipate continuing or expanding on this 
research project in the future? If yes, please explain. 
Yes, this project is still ongoing and we anticipate 
it will continue for some time. More research can 
be done exploring the structure as well as the 
effect that different nanoparticle coatings and 
different lipid chain lengths have on the 
characteristics of the bubbles. 
If you were to do your project again, what would you do 
differently? 
Having a better idea of the time and complexity of 
the initial steps would have helped planning the 
next steps. 
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Press Coverage (if applicable) 
 
One of the projects that we were involved in was testing of the use of magnetic nanoparticles for killing ocular 
cancer cells in vitro in collaboration with Kellogg Eye Center at the University of Michigan in Ann Arbor.  This 
work received coverage via local media and social media: 
 Kettering University News, “Kettering, University of Michigan researchers partner to transform ocular 
cancer treatment” by Pardeep Toor, 29 October 2014,  
http://www.kettering.edu/news/kettering-university-michigan-researchers-partner-transform-ocular-cancer-
treatment 
 Google Plus posting, Kellogg Eye Center, 30 October 2014, 
https://plus.google.com/+kelloggeyecenter/posts/fmoTgpd3TyT 
 DBusiness Daily News, “Kettering, U-M researchers treating ocular cancer without radiation,” 07 
November 2014,  
http://www.dbusiness.com/daily-news/Annual-2014/Kettering-U-M-Researchers-Treating-Ocular-Cancer-
without-Radiation/ 
 MLive.com, “Kettering University professor helps develop new technique to fight ocular cancer” by Sarah 
Schuch, 12 November 2014, 
http://www.mlive.com/news/flint/index.ssf/2014/11/kettering_university_professor_14.html  
 University of Michigan Kellogg Eye Center 2014‒15 Annual Report, “Collaborations in ocular oncology: 
Using thermal energy to eliminate side effects in eye cancer therapies,” p. 15, available at 
http://issuu.com/u-mkelloggeyecenter/docs/ar_2014_055b4d66b24bfc?e=6943966/10813102 
Examples of this press coverage are included in Appendix B. 
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Expenditures 
 
Expenditure Table 
 
Item  Please explain how this expense relates to 
your project as outlined in your proposal. 
Cost 
Mesh basket for ultrasonic bath 
The mesh basket is used to hold the 
magnetic nanoparticle samples during the 
coating process. 
$81.08 
Hemacytometer 
(phase-contrast, bright-line) 
The hemacytometer are used to size and 
count the magnetic microbubbles. 
$179.93 
Adjustable Pipettor (0.5 to 10 μL), 
Adjustable Pipettor (10 to 100 μL), 
Adjustable Pipettor (100 to 1000 μL) 
The adjustable pipetters are used to 
dispense liquids during magnetic 
nanoparticle and microbubble synthesis 
and characterization. 
$559.80 
Iron (II) Chloride Tetrahydrate,  
Iron (II) Chloride Tetrahydrate, 
Sodium hydroxide concentrate, 
Ammonium hydroxide solution,  
Hydrochloric acide solution, 
Oleic acid 
These chemical supplies are used to 
synthesize magnetic nanoparticles, except 
for the oleic acid. The oleic acid is used to 
create a hydrophobic coating for the 
magnetic nanoparticles. 
$410.69 
Dextran (low fraction) 
Dextran is used to create a hydrophilic 
coating for the magnetic nanoparticles to 
make them stable in an aqueous solution. 
$132.46 
Fluorescein isothiocyanate (FITC), 
Epichlorohydrin 
These supplies are used to functionalize 
the coatings on the magnetic  
nanoparticles (i.e., to cross-link and 
florescently label them). 
$107.68 
Separatory funnel 
The funnel is custom-made glassware 
used to synthesize the magnetic 
nanoparticles. 
$258.86 
Dialysis device 
Dialysis devices are used to remove 
excess sodium hydroxide introduced in the 
synthesis procedure of the magnetic 
nanoparticles. 
$108.90 
Phosphatidylcholine This phospholipid is used to create the shell around the magnetic microbubbles. 
$205.85 
 Slight overage covered by external support 
($48.25) 
Total of Expenses Covered by SPS Funding  $1997.00 
 
Note: The figures shown in this final expense report may differ slightly from the midyear 
report, as these final figures account for the total costs including shipping and handling. 
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Significant support for this project was covered by other sources of funding from Kettering 
University to faculty advisors (Prof. Ronald Kumon, Prof. Prem Vaishnava): 
 
Item  Please explain how this expense relates to 
your project as outlined in your proposal. 
Cost 
Ultrasonic bath sonicator The bath sonicator is used to more gently coat magnetic nanoparticles than the  
$828.00 
Probe sonicator The probe sonicator is used to disperse 
magnetic nanoparticles and create 
magnetic microbubbles. 
$2250.00 
Sound enclosure 
This hand-made enclosure is used to 
reduce the loud, high-pitched sound 
generated by the probe sonicator for 
occupational health & safety. 
$90.88 
Microscope slides & cover slips Microscope slides and cover slips are used 
to view magnetic microbubbles. 
$5.25 
Benchtop protectors These protectors are used to protect the 
benchtops from chemical spills. 
$37.22 
Immersion oil for microscope This oil is used to view magnetic 
microbubbles under a high magnification 
oil-immersion microscope objective. 
$8.50 
Phosphatidylcholine 
(hydrogenated & from egg yolk) 
This phospholipid is used to create the 
shell around the magnetic microbubbles.  $126.50 
Phosphate-buffered saline (PBS) 
tablet and 10X solution 
These supplies are used to create an 
aqueous solution that is osmotically 
balanced for use with cells. 
$86.55 
Refrigerator/freezer This small refrigerator/freezer is used to store chemical supplies. 
$119.00 
Nitrile gloves 
(small, medium, & large) 
These gloves are used during the synthesis 
of the magnetic nanoparticles and 
microbubbles for occupational health & 
safety. 
$114.04 
Sharps container 
The sharps containers are used during 
synthesis of the magnetic nanoparticles 
and microbubbles to collect broken glass 
or other sharp metal tips. 
$4.86 
Digital thermometer 
The thermometer is used to monitor 
temperature of the solution during 
nanoparticle synthesis. 
$18.38 
Beakers & graduated cylinders This glassware is used during the synthesis of magnetic nanoparticles. 
$183.97 
Pasteur pipettes & dropper bulbs These pipettes are used during the synthesis of magnetic nanoparticles. 
$62.38 
Wash bottles These bottles are used to clean glassware and provide water during experiments. 
$42.42 
Microcentrifuge tube rack 
These racks are used to hold the 
microcentrifuge tubes used to hold the 
magnetic nanoparticles samples. 
$26.81 
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Paraffin wrapping film This film is used to seal containers as part of the magnetic nanoparticle synthesis 
$20.83 
Wipes The wipes are used to clean up minor spills during experiments 
$4.46 
pH paper 
This paper was used during the early 
magnetic nanoparticle synthesis 
procedures to intermittently estimate pH 
of the solution. 
$10.09 
pH sensor & storage solution 
The pH meter was used during the later 
magnetic nanoparticle synthesis 
procedures to continuously measure pH of 
the solution. 
$98.58 
Labelling tape This tape is used to label samples of magnetic nanoparticles & microbubbles. 
$5.06 
Magnetic retreiver 
The retreiver is used to retrieve the 
magnetic stir bar used during parts of the 
magnetic nanoparticle synthesis. 
$8.88 
Weighing dishes (small & large) 
The dishes are used to weigh out 
powdered chemical supplies during the 
magnetic nanoparticle synthesis & 
characterization. 
$110.53 
Chemical waste containers 
The containers are used to dispose of 
waste products from the magnetic 
nanoparticle and microbubble synthesis. 
$5.36 
Transmission electron microscope 
user fees 
These fees were paid to a transmission 
electron microscope user facility at 
Michigan State University to characterize 
the size and shape of the magnetic 
nanoparticles. 
$150.00 
Poster printing 
The university covered the cost of printing 
two posters to be presented at the annual 
Homecoming poster session. 
$60.00 
 Slight overage covered by external support 
$48.25 
Total of Expenses Covered by Other Support  $4607.88 
 
Expenditure Table 
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Activity Photos 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. TEM image of MNP coated with dextran. [Image by X. Zhou] 
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Figure 2. Heating curve of frozen ferrofluid undergoing magnetic fluid hyperthermia with magnetic field 
oscillating at 150 kHz. [Figure by Nathaniel Mosher] 
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Figure 3. The left image shows magnetic microbubbles forming chains as they align with the magnetic field, 
indicated by the arrow. The right image shows the same bubbles without a magnetic field. The large, dark spots 
are clusters of excess nanoparticles that did not join with the bubbles. The images were taken at 20X 
magnification. [Images by Emily Perkins-Harbin] 
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Appendix A: Examples of Disseminated Products 
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Enhancing Cancer Treatment with 
Magnetic Fluid Hyperthermia (MFH)
(Lockwood, 2011)
Current treatments can be improved upon
How does MFH work?
Applications/Research
MFH as a cancer treatment option may have significant 
advantages over current treatments 
(Nanoprobes.com, 2014)
(Seniorscientific.com, 2014)
2Chemotherapy 
The problem: Chemo and radiation therapy kill healthy 
cells which can lead to serious side effects
Radiation therapy
(Martino et al., 2013) (Online Degrees, 2013)
40
50
°C
Cancer
cells start 
dying
Healthy
cells start 
dying
Hyperthermia uses heat to kill cells
30(Autoren, 2014)
3We can use magnetic nanoparticles to provide 
targeted heating, limiting side effects
Tumor
Fluorescing 
Nanoparticles
(Yuan et al., 2014)
The heat generated is used to kill cancer
(Hayashi et al., 2013)
4(Lee et al., 2011)
The magnetic fluid used in MFH is comprised of 
magnetic nanoparticles
5Nanoparticles are so small they only have one 
domain
Nanoparticles align with a magnetic field in two 
different ways
B
Neel Brownian
6Treatment of prostate with MFH is currently in 
human trials in Germany
(Johannsen et al., 2006)
There is research being done on using MFH to treat GBM, a 
very deadly tumor with no other form of treatment
(Mahmoudi and Hadjipanayis, 2014)
7Targeted means that only 
cancer cells get killed
Fewer side effects
Enormous number of 
research paths to explore
Questions?
In conclusion, MHF has the potential to replace or enhance 
the current methods of treating cancer
(Seniorscientific.com, 2014)
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Determination of the magnetocrystalline anisotropy
constant from the frequency dependence of the specific ab-
sorption rate in a frozen ferrofluid1 NATHANIEL MOSHER,
EMILY PERKINS-HARBIN, BRANDON AHO, Kettering University
Department of Physics, LIHUA WANG, Kettering University De-
partment of Chemistry and Biochemistry, RONALD KUMON, COR-
NELIU RABLAU, PREM VAISHNAVA, RONALD TACKETT, Ket-
tering University Department of Physics, THERAPEUTIC BIOMATE-
RIALS GROUP TEAM — Colloidal suspensions of superparamagnetic
nanoparticles, known as ferrofluids, are promising candidates for the me-
diation of magnetic fluid hyperthermia (MFH). In such materials, the
dissipation of heat occurs as a result of the relaxation of the particles
in an applied ac magnetic field via the Brownian and Neel mechanisms.
In order to isolate and study the role of the Neel mechanism in this
process, the sample can be frozen, using liquid nitrogen, in order to
suppress the Brownian relaxation. In this experiment, dextran-coated
Fe3O4 nanoparticles synthesized via co-precipitation and characterized
via transmission electron microscopy and dc magnetization are used as
MFH mediators over the temperature range between -70 ◦C to -10 ◦C
(Brownian-suppressed state). Heating the nanoparticles using ac mag-
netic field (amplitude∼300 Oe), the frequency dependence of the specific
absorption rate (SAR) is calculated between 150 kHz and 350 kHz and
used to determine the magnetocrystalline anisotropy of the sample.
1We would like to thank Fluxtrol, Inc. for their help with this project
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Kettering, University of Michigan researchers partner 
to transform ocular cancer treatment 
Oct 29, 2014 
"We have documented proof that our procedure would kill cancer cells without 
using chemotherapy and/or radiation.” 
Dr. Prem Vaishnava is working on a new technique to treat ocular cancer. 
A newfound partnership between Dr. Prem Vaishnava, professor of Physics at Kettering 
University, and Dr. Hakan Demirci at the University of Michigan Kellogg Eye Center is 
attempting to forever change the treatment of ocular cancer in the United States through 
a targeted and precise technique that has proven to mitigate the disease without the 
side effects of chemotherapy and radiation. 
“We are confident our technique would work because we have results of preliminary 
testing in a petri dish,” Vaishnava said. “We have documented proof that our procedure 
would kill cancer cells without using chemotherapy and/or radiation.” 
The treatment uses magnetic nanoparticles and magnetic microbubbles to specifically 
target Chorodial Melanoma and Retinoblastoma – both cancers of the eye. This 
technique is currently being used to treat cancer in humans in Europe but has not yet 
been approved in the United States. 
 “The science is there and there’s proof that it works. Phase I and Phase II trials have 
been conducted successfully using magnetic nanoparticles in animals in the United 
States,” Vaishnava said. 
How It Works 
Demirci is an oncology specialist at the Kellogg Eye Center in Ann Arbor. He reached 
out to Vaishnava to express his interest in using magnetic nanoparticles and 
hyperthermia to treat eye cancer. In a simple experiment, retinoblastoma cancer cells 
were mixed with magnetic nanoparticles in a petri dish and the mixture was exposed to 
an alternating magnetic field of frequency 350 kHz. The magnetic nanoparticles 
produced heat which is sufficient to kill cancer cells and the healthy cells remain 
unharmed. 
In several instances heat is also provided by 
microware. Vaishnava explains that this treatment 
can be a bit “nasty” because an antenna is needed 
to be placed underneath the skin near the eye ball 
to heat the tumor. The procedure burns the skin and tissues during the installation of the 
antenna. Magnetic nanoparticles do not have such side effects. 
Magnetic nanoparticles are iron oxide molecules that are suspended in a solution and 
can be injected into the body or directly into tumor without any harm. Once injected, 
particles disperse randomly, however, what Vaishnava has determined that if a magnet 
is positioned around the region where the cancer is located in the eye, the magnetic 
nanoparticles will be attracted to that site. Once they are concentrated around the the 
cancer site, a magnetic field can be applied which will cause the nanoparticles to 
oscillate or “dance” giving off heat and killing cancer cells. 
Using this exact principle, Vaishnava and his research team (Professor Ron Kumon and 
students Nathaniel Mosher and Emily Perkins) have expanded on this technique by 
attaching anti-cancer drugs to the magnetic nanoparticles. Once the magnetic 
nanoparticles reach the cancer site, the drugs are released right on to the cancer site in 
the eye. 
“There are so many aspects to it,” Vaishnava said. “Although the principle looks very 
simple, when you start using it, there are so many challenges.” 
Going one step further, Vaishnava has plans to use “microbubbles” that are 1,000 times 
bigger than magnetic nanoparticles. Each “microbubble” is surrounded by magnetic 
nanoparticles and can burst with ultrasound to unleash a large concentrated amount of 
medication and nanoparticles at the cancer site.  
“We took retinoblastoma cancer cells and mixed them with magnetic nanoparticles in a 
petri dish, not even a microbubble, and we heated them at 42 degrees Celsius for three 
minutes and were surprised with the results - we killed 90 percent of the cancer cells.” 
Related: 
Using nano-technology to treat cancer
NSF grant will help Kettering acquire 
X-Ray diffractometer 
Next Steps 
Vaishnava in partnership with Demirci at the Kellogg Eye Center is seeking funding for 
Phase II trial which will involve treating mice with ocular cancers. In the future, Phase III 
trial will involve humans. 
“We are really excited because not only can we heat and kill cancer cells but we can 
deliver the drugs,” Vaishnava said. “Our procedure is a combination of limited 
chemotherapy and hyperthermia.” 
What is the greatest benefit of magnetic nanoparticle treatment? There are no side 
effects. 
“Because this is just heat, for human beings, they might feel some sensation of warmth 
at the site of the tumor,” Vaishnava said. 
Despite the concentrated and precise nature of the treatment, Vaishnava suggests that 
magnetic nanoparticle treatment will be most effective when combined with traditional 
forms of therapies such as radiation and chemotherapy in order to ensure that cancer 
cells aren’t lingering in other parts of the body. A tandem approach to treatment can 
also have complementary results. 
“There are some tumors which are resistant to radiation and chemotherapy. This is 
because of their hypoxic nature.” Vaishnava said. “By heating the tumor, we can 
increase the profusion rate increasing the amount of oxygen in the tumor.  Both 
radiation and chemotherapy have a greater impact when there’s rich oxygenated blood 
flow to the cancer site.” 
For now, Vaishnava and his colleagues will continue to perfect the science and 
techniques as they proceed through the various phases before this technique receives 
widespread approval for use in the United States. 
“There’s a great demand for this kind of work. This is a step forward in melanoma and 
retinoblastoma treatment,” Vaishnava said. 
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Researchers at Kettering
University and the
University of Michigan
Kellogg Eye Center are
finding early success in
developing a treatment
that kills ocular cancer
cells without using
chemotherapy or
radiation.
“The science is there and
there’s proof that it works,” says Prem Vaishnava, professor of physics at Kettering University
in Flint, who is working on the project with Dr. Hakan Demirci at U­M in Ann Arbor.
Vaishnava says the technique is now being used in Europe, but has not been approved in the
United States.
 The treatment uses magnetic nanoparticles — iron oxide molecules that are suspended in a
solution and can be injected into the body or directly into a tumor — to target Chorodial
Melanoma and Retinoblastoma, both cancers of the eye.
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“Phase I and Phase II trials have been conducted successfully using magnetic nanoparticles in
animals in the United States," Vaishnava says.
Once injected, magnetic nanoparticles can be guided to the cancer in the eye by using a
magnet positioned around the given area. Once they are concentrated around the cancer site,
a magnetic field can be applied, causing the nanoparticles to oscillate and give off heat,
thereby killing cancer cells.
The researchers have expanded the technique by attaching anti­cancer drugs to the magnetic
nanoparticles. Once the magnetic nanoparticles reach the cancer site, the drugs are released
right on to the cancer site in the eye.
Vaishnava says future plans are to use microbubbles, which are 1,000 times bigger than
magnetic nanoparticles, in the tests. Each microbubble is surrounded by magnetic
nanoparticles and can burst with ultrasound to release a large, concentrated amount of
medication and nanoparticles at the cancer site.
“We took retinoblastoma cancer cells and mixed them with magnetic nanoparticles in a petri
dish, not even a microbubble, and we heated them at 42 degrees Celsius for three minutes
and were surprised with the results — we killed 90 percent of the cancer cells,” he says.
The researchers are seeking funding for Phase II trials, which will involve treating mice with
ocular cancers. In the future, Phase III trial will involve humans.
This article appears in the Annual 2014 issue of Daily News
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Kettering professor Prem Vaishnava is working on a new technique to
treat ocular cancer that doesn't require radiation or chemotherapy.
 
Kettering University professor helps develop new  technique to
fight ocular cancer
Sarah Schuch | sschuch@mlive.com By Sarah Schuch | sschuch@mlive.com 
on November 12, 2014 at 1:00 PM, updated November 12, 2014 at 2:07 PM
FLINT, MI -- One Kettering University
professor hopes to change the way the health
community looks at treatment for ocular
cancer. 
Prem Vaishnava, Kettering physics professor, partnered with Hakan Demirci at the University of Michigan
Kellogg Eye Center to develop a new technique to fight ocular cancer without the use of radiation or
chemotherapy. 
The treatment uses magnetic nanoparticles and magnetic microbubbles to specifically target Chorodial
Melanoma and Retinoblastoma – both cancers of the eye.
So far in 2014 there have been 2,730 new cases of cancers of the eye and orbit in the United States -- 1,440 in
men and 1,290 in women -- according to the American Cancer Society. 
There has been 310 deaths from cancers of the eye and orbit so far this year, according to the American Cancer
Society's website.
This technique being tested by Vaishnava and Demirci is currently being used to treat cancer in humans in
Europe but has not yet been approved in the United States, according to a release.
"The science is there and there's proof that it works. Phase I and Phase II trials have been conducted
successfully using magnetic nanoparticles in animals in the United States," Vaishnava said in a written
statement. 
How does it work? 
In a simple experiment, retinoblastoma cancer cells were mixed with magnetic nanoparticles in a petri dish and
the mixture was exposed to an alternating magnetic field of frequency 350 kHz. The magnetic nanoparticles
produced heat which was sufficient to kill cancer cells and the healthy cells remain unharmed.
Using that same principle, Vaishnava and his research team have expanded on the technique by attaching drugs
to a magnet and then guiding that magnet to another magnet underneath the eye.
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The drugs are released right on to the cancer site in the eye.
Now the team hopes to move forward in the research. 
Vaishnava in partnership with Demirci at the Kellogg Eye Center is seeking funding for Phase II trial which will
involve treating mice with ocular cancers. In the future, Phase III trial will involve humans.
"There's a great demand for this kind of work. This is a step forward in melanoma and retinoblastoma
treatment," Vaishnava said in a written statement.
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Excerpt from University of Michigan Kellogg Eye Center 2014‒15 Annual Report, 
“Collaborations in ocular oncology: Using thermal energy to eliminate side effects in eye cancer 
therapies,” p. 15, available at  
http://issuu.com/u-mkelloggeyecenter/docs/ar_2014_055b4d66b24bfc?e=6943966/10813102 
 
 
